10.5281/zenodo.1173004
https://zenodo.org/records/1173004
oai:zenodo.org:1173004
Roslin Adamson
Roslin Adamson
University of Oxford
Mizio Matteucci
Mizio Matteucci
University of Oxford
Paul E. Brennan
Paul E. Brennan
University of Oxford
Alex N. Bullock
Alex N. Bullock
University of Oxford
Purification of ACVR1 for co-crystallisation with LDN-193189 and other compounds
Zenodo
2018
purification, ACVR1, LDN-193189, crystallisation
2018-02-14
10.5281/zenodo.1173003
https://zenodo.org/communities/sgc-opennotebook
Creative Commons Attribution 4.0 International
Purification of constitutively active ACVR1 for co-crystallisation with LDN-193189 and three other compounds.
The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada, Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA Darmstadt Germany, MSD, Novartis Pharma AG, Ontario Ministry of Economic Development and Innovation, Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome [106169/ZZ14/Z].